G. W. Hosier and N. J. Touma, “Response of renal cell carcinoma to ibrutinib, a bruton tyrosine kinase inhibitor, in a patient treated for chronic lymphocytic leukemia”, CUAJ, vol. 11, no. 5, pp. E237–9, May 2017.